Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression
- PMID: 32181990
- PMCID: PMC7228349
- DOI: 10.1111/ajt.15869
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression
Abstract
The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia.
Keywords: COVID-19; coronavirus; immunosuppression; pneumonia; renal transplantation.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures


Comment in
-
Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19.Ann Rheum Dis. 2020 Jun;79(6):737-739. doi: 10.1136/annrheumdis-2020-217460. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295789 No abstract available.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. [published online ahead of print 2020]. 10.1001/jama.2020.2648. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical